Background: MicroRNAs (miRNAs) negatively regulate the gene expression and act as tumor suppressors or oncogenes in carcinogenesis. The association between single nucleotide polymorphism (SNP) in miR-196a2 rs11614913 and the susceptibility of digestive system cancers was inconsistent in previous studies. Methods: A standardized search of PubMed, Embase, and Cochrane library databases for publications on miR-196a2 rs11614913 polymorphism and digestive system cancer risk was performed. Then the genotype data were analyzed in a meta-analysis. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the association. Test of heterogeneity, sensitivity analysis and assessment of publication bias were conducted in the present meta-analysis by STATA software 12.0. Results: An updated metaanalysis based on 34 independent case-control studies consisting of 13,013 cases and 16,046 controls was performed to address this association. There was a remarkable association between miR-196a2 rs11614913 polymorphism and overall digestive system cancer risk, especially in Asian populations. Moreover, subgroup analysis revealed that variant C allele increased risk of colorectal carcinoma, gastric cancer and hepatocellular carcinoma (HCC), compared with wild T allele. Conclusions: There was a remarkable association between miR-196a2 rs11614913 polymorphism and overall digestive system cancer risk, especially in Asian populations.
Introduction
MicroRNAs (miRNAs) are a kind of evolutionarily highly conserved, non-coding, single-stranded RNAs with the length of about 22 nucleotides (nt). MiRNAs play crucial roles in a board range of biological processes, including cell differentiation, proliferation, apoptosis and carcinogenesis [1] . The miRNAs regulate the expression of approximately 10% -30% of all human genes through post-transcriptional mechanism pairing to 3'-untranslated region (3'UTR) of target messenger RNA (mRNA), leading to mRNA degradation or translational repression [2] . Accumulating studies have demonstrated that this novel kind of gene regulators got involved in cancer-related process [3] . The loss and gain of function of some specific miRNAs were also considered to be crucial events in diverse cancers [4] . Although the precise mechanism of how miRNAs mediate carcinogenesis still remains ambiguous, genetic alterations of miRNAs are supposed to be a key event [5] .
Single-nucleotide polymorphisms (SNPs) are defined as variation of a single nucleotide (A, T, C, or G) in DNA sequence that occurs at least 1% in certain populations. As the most common type of variation in the human genome, SNPs can influence the population diversity, disease susceptibility, and individual response to medicine by affecting sequence coding and splicing [6] . SNPs in miRNA-coding genes may affect processing and binding ability of miRNAs by altering the secondary structure of miR-NA precursors, resulting in aberrant expression of a series of target genes and contributing to cancer susceptibility [7] . Hu et al. [8] first reported that SNP miR196a2 rs11614913 was associated to non-small cell lung cancer survival and the CC genotype presented a significant correlation with mature has-mir-196a expression but not with changes in levels of its precursor, suggesting that the process of the pre-miRNA to its mature form was enhanced. Hoffman et al. [9] found that rs11614913 not only has an impact on the level of mature miR-196a, but also influences the expression of target genes. Numerous epidemiological studies have demonstrated the association of SNPs in miRNAs with the development and progression of cancer [7] [10] . Furthermore, the association between hsa-miR-196a2 rs11614913 polymorphism and cancer risk has been analyzed in several studies, but the conclusions of these studies remain inconsistent due to heterogeneity of the cancer subtype, limited sample size, and differences in the ethnicity of patients. To reduce the potential between-study heterogeneity which might derive from various cancers in diverse systems and improve the efficiency of meta-analysis on digestive cancers, we only focused on digestive system cancers. Therefore, we conducted this meta-analysis to derive a more precise estimation of the association of miR-196a2 rs11614913 with digestive system cancer risk.
Materials and Method

Publication Search
To identify all potentially eligible studies, we conducted a comprehensive literature search in PubMed, Embase, and Cochrane library databases between 2000 and Sep-tember 2016 (last updated on September 21st, 2016) with the following search strategy: "miR-196a2 or microRNA-196a2 or rs11614913"; "SNP or polymorphism or mutation or variant or allele" and "cancer or tumor or carcinoma or neoplasm". The references of retrieved articles were also screened to search other potentially related articles. Studies containing two or more case-control groups were considered as two or more independent studies.
Selection Criteria
Eligible studies were selected according to the following explicit inclusion criteria: I) evaluation of miR-196a2 polymorphism and digestive system cancer risk; II) independent case-control studies for human; III) sufficient published data for calculating odds ratios (ORs) with their 95% confidence intervals (95% CIs); IV) cases with carcinomas were diagnosed by histopathology; V) published in English or Chinese.
Data Extraction Methodological Assessment
Two investigators (Zhao and Zhou) independently extracted information from eligible studies using a standardized data collection protocol: first author's name, year of publication, country of origin, ethnicity, cancer type, genotyping method, source of control groups, whether verified Hardy-Weinberg equilibrium (Table 1) , C allele frequency in controls, and genotype frequency distribution. If original genotype frequency data was unavailable in relevant articles, a request for additional data was sent to the corresponding author. Disagreements were resolved by discussion between the two investigators.
The same authors evaluated the methodological quality of the included studies using the Newcastle-Ottawa Scale (NOS) criteria, independently [11] . The NOS criteria are scored based on three aspects: 1) subject selection: 0 -4, 2) comparability of subject: 0 -2, and 3) clinical outcome: 0 -3. Total NOS scores ranged from 0 to 9, with scores ≥ 7 indicating good quality.
Statistical Analysis
Hardy-Weinberg equilibrium (HWE) in control subjects was tested by the Chi-square goodness-of-fit test. It was considered to be a state of disequilibrium with P-value less than 0.05. Crude ORs and 95% CIs were used to assess the strength of the association between the miR-196a2 rs11614913 polymorphism and digestive system cancer risk. CT + TT) and allele model (C vs. T), respectively. Subgroup analyses were also conducted by cancer type, ethnicity (Caucasian and Asian), source of control (populationbased and hospital-based), and HWE in controls. The significance of the pooled OR was determined by the Z test in which P value < 0.05 was considered statistically significant.
We used chi-square-based Q-test and the I 2 index to determine the heterogeneity among different studies. The Galbraith plot was used to detect the potential sources of heterogeneity. The random-effect model was used when heterogeneity was considered significant (P-value < 0.10 and/or I 2 index > 50%); otherwise, the fixed-effects model was conducted. In addition, potential publication bias was evaluated using Begg's funnel plot, Begg's test and Egger's test. Asymmetric funnel-shaped plots or P < 0.05 was considered the existence of publication bias. We conducted one-way sensitivity analysis to assess the stability of the results. One single study was excluded each time to reflect the influence of the individual data set to the pooled ORs.
All statistical analyses were carried out with STATA software version 12.0 (STATA Corp, College Station, TX). All the P values were two-sided.
Results
Studies Characteristic
In total, 32 eligible studies [12] - [43] including 34 data sets were collected according to the inclusion criteria, with 13013 cases and 16046 controls ( Figure 1 ). Characteristics of these studies were shown in Of all the including studies, 4 were on oral squamous cell carcinoma (OSCC), 2 were on pharyngeal squamous cell carcinoma (PSCC), 11 were on hepatocellular carcinoma (HCC), 6 were on gastric cancer (GC), 1 was on gallbladder cancer (GBC), 4 were on esophageal squamous cell carcinoma (ESCC), and 6 were on colorectal carcinoma (CRC). The subjects of 25 studies were Asian and the other 9 studies were Caucasian. Matching for age and sex, controls of 25 studies were hospital-based and 9 studies were population-based. Genotype distribution of controls in most studies was in agreement with HWE (Table 1) .
Quantitative Synthesis
The association strength of miR-196a2 rs11614913 polymorphism and the susceptibility for digestive system cancers is presented in Table 2 .
Significant association between miR-196a2 rs11614913 polymorphism and the risk of digestive system cancers were observed in all comparisons (CC vs.TT: OR = 1.317, 95%CI 1.119 -1. Cancer types, source of controls, ethnicity and HWE in controls were taken into consideration for subgroup analysis ( Table 2 
Evaluation of Heterogeneity
Heterogeneity between studies was observed in overall comparisons (data not shown). N.: number of involved studies; OR: odds ratio; 95%CI: 95% confidence interval; P: values of significance; P Q : values of Q test for heterogeneity; Random model was used for data pooling when P Q < 0.10 or I 2 > 50%; otherwise fixed model was used; The results marked in boldface indicates statistical significance.
After stratification, the heterogeneities decreased merely in the subgroups of CRC (P Q ≥ 0.10 and I 2 < 50%). But we found that the variable ethnicity, source of controls and HWE status could not explain heterogeneity (data not shown).
Sensitivity Analysis
In the sensitivity analysis, the influence of each study on the pooled OR was checked by repeating the meta-analysis while deleting each study, one at a time. The significance of pooled ORs was not influenced materially by omitting any single study (Figure 3) .
Moreover, sensitivity analysis was performed by omitting the studies conducted by Zhang et al., Shen et al., and Sushma et al. [39] [42] [43] in which the control groups
were not in accordance with HWE. The significance of all ORs remained unaltered after excluding these 3 studies.
Publication Bias
Begg's funnel plot, Begg's test and Egger's tests were performed to evaluate publication bias of the literature on digestive system cancers. 
Discussion
MiRNAs get involved in various biological and pathological processes and are regarded as a key component in carcinogenesis. SNPs are the most common sequence variation in the human genome [44] . SNPs could alter sequences' coding and binding ability, thus modifying the cancer susceptibility in population. Recently, many studies demonstrated that SNPs in miR196a2 rs11614913 was significantly associated with the susceptibility of diverse cancers. Tong et al. [45] observed that CT and CC/CT genotypes were 1.40, 95%CI = 1.09 -1.79; respectively). On the contrary, Du et al. [46] found that carriers of CC genotype had a significantly decreased risk for renal cell cancer, compared with the carriers of CT/TT genotype.
Moreover, several meta-analyses have been conducted on the association between SNPs in miR196a2 and cancer risk, but a unanimous conclusion still has not been achieved. Given the controversial result, we performed this meta-analysis to clarify the association of this variant with digestive system cancer risk. Compared to Guo et al.'s meta-analysis published in 2011 [47] , we included another 19 studies, which kept our results more stable and authentic.
In the present meta-analysis, we observed a significant association between rs11614913 and increased risk in digestive system cancers. However, when stratified by cancer type, rs11614913 merely displayed relevance with CRC, HCC and gastric cancer. This may be explained by the effect of gene polymorphism on cancer susceptibility varies by specific cancer type. Otherwise, the relatively small amount of eligible studies in stratified analysis might induce statistically significant or insignificant association by chance due to insufficient statistical power [48] . In addition, we observed that rs11614913 polymorphism presented a risk factor in Asians, but not in Caucasians. The inconsistent results among different ethnicities may be due to diverse heredity backgrounds. And relatively small number of eligible studies with only 8 Caucasian studies included may be insufficient to detect statistical significance. Therefore, the results from the Caucasian subgroup should be treated with caution. Additional studies, especially Caucasians studies are urgently needed to further validate the ethnic differences in the effect of rs11614913
on digestive system cancer risk. Significant association was observed in both subgroups when stratified by source of control and HWE, which exactly supports the conclusion that rs11614913 polymorphism contribute to the susceptibility of digestive system cancers.
One of the major concerns in a sound meta-analysis is the stability of results, which is examined by sensitivity analysis. The pooled ORs kept unaltered during the sensitivity analysis. When excluding the studies that were inconsistent with HWE, the estimated pooled ORs still did not change at all, indicating that our results are reliable and robust.
Heterogeneity is a major problem that can distort the findings in meta-analysis. Obvious heterogeneity between studies was observed in overall comparisons and most subgroup analyses. In an attempt to find the sources of heterogeneity, a Galbraith plot was drawn (data not shown), and Dikeakos et al.'s study [30] was thought to serve as the main contributor for the heterogeneity. But the heterogeneity still kept considerable after excluding it, indicating that there may have other reasons for the heterogeneity.
Then we conducted stratified analysis to reduce heterogeneity, but we found that the variable ethnicity, source of controls, and HWE status could not explain heterogeneity.
Notably, in the current study, only studies published in English or Chinese were included, which may partially explain the intractable heterogeneity. Another important problem for any meta-analysis is publication bias due to selective publication of reports. In this meta-analysis, both the shape of funnel plots and statistical results did not show publication bias, suggesting reliability of our study.
Nevertheless, some limitations of this meta-analysis should be addressed. Firstly, oncogenesis is influenced by various factors such as genetic factors, tumor biological characteristics environmental damage, while we only focused on the variant in miRNAs.
Secondly, our analysis was limited to Asian and Caucasian ethnicities, which limited the general application of the findings from the meta-analysis. Thirdly, only studies published in English and Chinese were included in our meta-analysis. The exclusive reliance on English and Chinese studies may not represent all of the evidence. Excluding languages other than English or Chinese may introduce a language bias and lead to erroneous conclusions. In addition, many studies with negative data, such as absence of links to cancer risks and progression, are most times not considered for submission by researchers, resulting in unavoidable bias. But fortunately, our results of publication bias test show this bias is limitable and acceptable.
Conclusion
In summary, our meta-analysis reveals that miR196a2 rs11614913 polymorphism contributes to increased digestive system cancer susceptibility, especially in Asian populations. Further, well-designed studies with diverse ethnic groups and larger sample size are required to validate this association.
